Overview

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

Status:
Active, not recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

The study is aimed to evaluate efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.

Phase:

N/A

Details

Lead Sponsor:

Istituto Clinico Humanitas